Xagenic

closed

Molecular diagnostics company developing a true point- of-care platform.

Launch date

2010

Market cap

Enterprise valuation

Toronto Ontario (HQ)

Date	Investors	Amount	Round
-	Domain Associates	N/A	-
Jan 2010	Toronto Innovation Acceleration Partners	$2.2m	Seed
Feb 2011	MaRS Investment Accelerator Fund	N/A	Seed
Jan 2012	Qiagen CTI Life Sciences Venture Ontario	$10.0m	Series A
Feb 2013	Government of Canada	$990k	Grant
Dec 2013	N/A	$9.6m	Early VC
Jul 2014	BDC Capital (Canada) CTI Life Sciences Ontario Capital Growth Business Development Bank of Canada (BDC)	$25.5m	Series B
Jul 2015	BDC Capital (Canada) CTI Life Sciences Ontario Capital Growth	$15.0m	Series B
Total Funding		CAD86.3m

Tech stackLearn more about the technologies and tools that this company uses.

Recent News about Xagenic